| scholarly article | Q13442814 |
| P50 | author | Imogen Coe | Q49561445 |
| P2093 | author name string | Holger K Eltzschig | |
| Sean P Colgan | |||
| Karen A Westerman | |||
| Andreas Robinson | |||
| Caroline Schönfeld | |||
| Dionne Daniels | |||
| Edgar Hoffman | |||
| German Reyes | |||
| Jorn Karhausen | |||
| Kathryn E Hamilton | |||
| Michael Duszenko | |||
| Michaela Löffler | |||
| Parween Abdulla | |||
| P2860 | cites work | Cloning of a human nucleoside transporter implicated in the cellular uptake of adenosine and chemotherapeutic drugs | Q24310832 |
| Regulation of hypoxia-inducible factor 1alpha is mediated by an O2-dependent degradation domain via the ubiquitin-proteasome pathway | Q24672316 | ||
| Coordinated adenine nucleotide phosphohydrolysis and nucleoside signaling in posthypoxic endothelium: role of ectonucleotidases and adenosine A2B receptors | Q24672615 | ||
| Crucial role for ecto-5'-nucleotidase (CD73) in vascular leakage during hypoxia | Q24817161 | ||
| A new mathematical model for relative quantification in real-time RT-PCR | Q27860781 | ||
| The equilibrative nucleoside transporter family, SLC29 | Q28184224 | ||
| Role of G-protein-coupled adenosine receptors in downregulation of inflammation and protection from tissue damage | Q28214799 | ||
| Nucleoside transporter subtype expression and function in rat skeletal muscle microvascular endothelial cells | Q28570384 | ||
| Oxygen sensing by HIF hydroxylases | Q29617806 | ||
| Molecular approach to adenosine receptors: receptor-mediated mechanisms of tissue protection | Q30307082 | ||
| Cell density mediated pericellular hypoxia leads to induction of HIF-1alpha via nitric oxide and Ras/MAP kinase mediated signaling pathways | Q30308414 | ||
| Morphological and functional techniques for assessing endothelial integrity: the use of Evans blue dye, silver stains, and endothelial derived relaxing factor | Q30458198 | ||
| Perspectives on oxygen sensing | Q33718248 | ||
| Correction of sickle cell disease in transgenic mouse models by gene therapy | Q34105099 | ||
| Neutrophil-derived glutamate regulates vascular endothelial barrier function | Q34114299 | ||
| Neutrophil migration across a cultured intestinal epithelium. Dependence on a CD11b/CD18-mediated event and enhanced efficiency in physiological direction | Q34209118 | ||
| Glycine 154 of the equilibrative nucleoside transporter, hENT1, is important for nucleoside transport and for conferring sensitivity to the inhibitors nitrobenzylthioinosine, dipyridamole, and dilazep | Q34307816 | ||
| The adenosine transporter, mENT1, is a target for adenosine receptor signaling and protein kinase Cepsilon in hypoxic and pharmacological preconditioning in the mouse cardiomyocyte cell line, HL-1. | Q34319259 | ||
| Oxygen sensing, HIF-1alpha stabilization and potential therapeutic strategies | Q34573202 | ||
| Ecto-5'-nucleotidase (CD73) regulation by hypoxia-inducible factor-1 mediates permeability changes in intestinal epithelia | Q34797847 | ||
| Mammalian nucleoside transporters | Q35668173 | ||
| Physiological control of immune response and inflammatory tissue damage by hypoxia-inducible factors and adenosine A2A receptors. | Q35698535 | ||
| Vascular ischaemia and reperfusion injury | Q35923162 | ||
| Hypoxia-inducible factor 1-dependent induction of intestinal trefoil factor protects barrier function during hypoxia | Q36369318 | ||
| Neutrophil-derived 5'-adenosine monophosphate promotes endothelial barrier function via CD73-mediated conversion to adenosine and endothelial A2B receptor activation | Q36404222 | ||
| Leukocyte adhesion during hypoxia is mediated by HIF-1-dependent induction of beta2 integrin gene expression | Q36672331 | ||
| Hypoxia-induced exocytosis of endothelial cell Weibel-Palade bodies. A mechanism for rapid neutrophil recruitment after cardiac preservation | Q37350527 | ||
| Endogenous adenosine produced during hypoxia attenuates neutrophil accumulation: coordination by extracellular nucleotide metabolism | Q38337539 | ||
| Epithelial hypoxia-inducible factor-1 is protective in murine experimental colitis. | Q40176806 | ||
| Hypoxia regulates the adenosine transporter, mENT1, in the murine cardiomyocyte cell line, HL-1. | Q40585734 | ||
| Regulation of adenosine receptor engagement by ecto-adenosine deaminase | Q40614831 | ||
| Hypoxia-inducible factor 1-mediated inhibition of peroxisome proliferator-activated receptor alpha expression during hypoxia | Q40801266 | ||
| Hypoxia-mediated induction of endothelial cell interleukin-1 alpha. An autocrine mechanism promoting expression of leukocyte adhesion molecules on the vessel surface | Q41022057 | ||
| Seeding of vascular grafts with an immortalized human dermal microvascular endothelial cell line | Q41377094 | ||
| HMEC-1: establishment of an immortalized human microvascular endothelial cell line | Q41592068 | ||
| Hypoxia-induced inhibition of adenosine kinase potentiates cardiac adenosine release | Q42442065 | ||
| In vitro and in vivo properties of novel nucleoside transport inhibitors with improved pharmacological properties that potentiate antifolate activity. | Q43670917 | ||
| Adenosine A2A receptor stimulation increases angiogenesis by down-regulating production of the antiangiogenic matrix protein thrombospondin 1. | Q45240162 | ||
| Intraoperative tissue oximetry in the human gastrointestinal tract. | Q45903026 | ||
| Transcriptional regulation of vascular endothelial cell responses to hypoxia by HIF-1. | Q51614218 | ||
| Plasma concentration of adenosine during normoxia and moderate hypoxia in humans. | Q54126699 | ||
| Measurement of nitrobenzylthioinosine in plasma and erythrocytes: a pharmacokinetic study in mice | Q73516086 | ||
| Protection of perfused lung from oxidant injury by inhibitors of anion exchange | Q73644928 | ||
| P433 | issue | 11 | |
| P407 | language of work or name | English | Q1860 |
| P921 | main subject | hypoxia | Q105688 |
| P304 | page(s) | 1493-1505 | |
| P577 | publication date | 2005-12-01 | |
| P1433 | published in | Journal of Experimental Medicine | Q3186912 |
| P1476 | title | HIF-1-dependent repression of equilibrative nucleoside transporter (ENT) in hypoxia | |
| P478 | volume | 202 |
| Q34208237 | 2,3,7,8-Tetrachlorodibenzo-p-dioxin induced cell-specific drug transporters with acquired cisplatin resistance in cisplatin sensitive cancer cells. |
| Q39670043 | A cell-based luciferase-dependent assay for the quantitative determination of free extracellular adenosine with paracrine signaling activity |
| Q37373680 | A(2B) adenosine receptors in immunity and inflammation. |
| Q64377116 | A1AR-mediated renal protection against ischemia/reperfusion injury is dependent on HSP27 induction |
| Q37336475 | A2B adenosine receptor dampens hypoxia-induced vascular leak |
| Q34826208 | A2B adenosine receptor signaling attenuates acute lung injury by enhancing alveolar fluid clearance in mice |
| Q47665974 | ATP induces PAD4 in renal proximal tubule cells via P2X7 receptor activation to exacerbate ischemic AKI. |
| Q33356018 | ATP release from vascular endothelia occurs across Cx43 hemichannels and is attenuated during hypoxia |
| Q36277823 | Adenosine Attenuates Human Coronary Artery Smooth Muscle Cell Proliferation by Inhibiting Multiple Signaling Pathways That Converge on Cyclin D. |
| Q24620924 | Adenosine and hypoxia-inducible factor signaling in intestinal injury and recovery |
| Q48045032 | Adenosine production by brain cells |
| Q33916975 | Adenosine protected against pulmonary edema through transporter- and receptor A2-mediated endothelial barrier enhancement |
| Q29346491 | Adenosine receptors as drug targets--what are the challenges? |
| Q34211096 | Adenosine transport by plasma membrane monoamine transporter: reinvestigation and comparison with organic cations |
| Q37360635 | Adenosine, adenosine receptors and their role in glucose homeostasis and lipid metabolism |
| Q33555006 | Adenosine: an old drug newly discovered |
| Q34184568 | Adora2b adenosine receptor engagement enhances regulatory T cell abundance during endotoxin-induced pulmonary inflammation |
| Q34999682 | Adverse and protective influences of adenosine on the newborn and embryo: implications for preterm white matter injury and embryo protection |
| Q36765972 | Altered Hypoxic-Adenosine Axis and Metabolism in Group III Pulmonary Hypertension |
| Q36916313 | Annexin A1 sustains tumor metabolism and cellular proliferation upon stable loss of HIF1A. |
| Q49224586 | Anti-inflammatory Effects of Heme Oxygenase-1 Depend on Adenosine A2A- and A2B-Receptor Signaling in Acute Pulmonary Inflammation. |
| Q27006863 | Attenuating myocardial ischemia by targeting A2B adenosine receptors |
| Q90183281 | Bidirectional transport of 2-chloroadenosine by equilibrative nucleoside transporter 4 (hENT4): Evidence for allosteric kinetics at acidic pH |
| Q37248599 | Biological implications of extracellular adenosine in hepatic ischemia and reperfusion injury |
| Q46016040 | CD73 protects kidney from ischemia-reperfusion injury through reduction of free radicals. |
| Q52338098 | Capturing the multifactorial nature of ARDS - "Two-hit" approach to model murine acute lung injury. |
| Q35140057 | Cardiac-specific ablation of ARNT leads to lipotoxicity and cardiomyopathy. |
| Q37039131 | Central role of Sp1-regulated CD39 in hypoxia/ischemia protection |
| Q58588096 | Changes in aortic reactivity associated with the loss of equilibrative nucleoside transporter 1 (ENT1) in mice |
| Q93161851 | Control and dysregulation of redox signalling in the gastrointestinal tract |
| Q58599331 | Coordination of ENT2-dependent adenosine transport and signaling dampens mucosal inflammation |
| Q45297840 | Cross sectional PET study of cerebral adenosine A₁ receptors in premanifest and manifest Huntington's disease |
| Q98735744 | Cross-Species Insights Into Genomic Adaptations to Hypoxia |
| Q37022867 | Crosstalk between the equilibrative nucleoside transporter ENT2 and alveolar Adora2b adenosine receptors dampens acute lung injury |
| Q30881980 | Cytoprotective effects of adenosine and inosine in an in vitro model of acute tubular necrosis |
| Q34599971 | Decreased extracellular adenosine levels lead to loss of hypoxia-induced neuroprotection after repeated episodes of exposure to hypoxia |
| Q37472011 | Detrimental role of the airway mucin Muc5ac during ventilator-induced lung injury. |
| Q41094641 | Dietary obesity-associated Hif1α activation in adipocytes restricts fatty acid oxidation and energy expenditure via suppression of the Sirt2-NAD+ system. |
| Q35410561 | Direct or indirect stimulation of adenosine A2A receptors enhances bone regeneration as well as bone morphogenetic protein-2. |
| Q42234787 | Disruption of spatiotemporal hypoxic signaling causes congenital heart disease in mice |
| Q38980570 | Downregulation of duodenal SLC transporters and activation of proinflammatory signaling constitute the early response to high altitude in humans |
| Q27343881 | EGL-9 controls C. elegans host defense specificity through prolyl hydroxylation-dependent and -independent HIF-1 pathways |
| Q39531156 | Ectonucleotidases CD39 and CD73 on OvCA cells are potent adenosine-generating enzymes responsible for adenosine receptor 2A-dependent suppression of T cell function and NK cell cytotoxicity. |
| Q24323818 | Endothelial catabolism of extracellular adenosine during hypoxia: the role of surface adenosine deaminase and CD26 |
| Q46026239 | Environmental triggers in IBD: a review of progress and evidence. |
| Q36724467 | Epigenetic changes within the promoter region of the HLA-G gene in ovarian tumors |
| Q38526404 | Equilibrative Nucleoside Transporters 1 and 4: Which One Is a Better Target for Cardioprotection Against Ischemia-Reperfusion Injury? |
| Q35698980 | Equilibrative nucleoside transporter 1 (ENT1) regulates postischemic blood flow during acute kidney injury in mice |
| Q37174112 | Equilibrative nucleoside transporter 1 plays an essential role in cardioprotection |
| Q30244329 | Equilibrative nucleoside transporters-A review |
| Q33613207 | Excess adenosine A2B receptor signaling contributes to priapism through HIF-1α mediated reduction of PDE5 gene expression |
| Q37157213 | Exercise training and peripheral arterial disease |
| Q36585539 | Extracellular adenosine signaling in molecular medicine |
| Q35193886 | Extracellular adenosine: a safety signal that dampens hypoxia-induced inflammation during ischemia |
| Q36699593 | Extracellular guanosine regulates extracellular adenosine levels |
| Q34047834 | Extracellular nucleotide and nucleoside signaling in vascular and blood disease |
| Q36217312 | Functional importance of Dicer protein in the adaptive cellular response to hypoxia |
| Q39694952 | Gemcitabine intercellular diffusion mediated by gap junctions: new implications for cancer therapy. |
| Q37618228 | Genetic factors influencing cytarabine therapy |
| Q34109802 | HIF-1 regulates iron homeostasis in Caenorhabditis elegans by activation and inhibition of genes involved in iron uptake and storage |
| Q38565092 | High altitude journeys and flights are associated with an increased risk of flares in inflammatory bowel disease patients |
| Q48895948 | Hypoxia and HIF-1 suppress SERCA2a expression in embryonic cardiac myocytes through two interdependent hypoxia response elements. |
| Q39131639 | Hypoxia and P1 receptor activation regulate the high-affinity concentrative adenosine transporter CNT2 in differentiated neuronal PC12 cells |
| Q37842498 | Hypoxia and inflammation |
| Q34087018 | Hypoxia increases the expression of stem-cell markers and promotes clonogenicity in glioblastoma neurospheres |
| Q33312383 | Hypoxia inducible factor (HIF)-1 coordinates induction of Toll-like receptors TLR2 and TLR6 during hypoxia |
| Q37061658 | Hypoxia inducible factor-1 (HIF-1)-mediated repression of cystic fibrosis transmembrane conductance regulator (CFTR) in the intestinal epithelium |
| Q34001111 | Hypoxia signaling controls postnatal changes in cardiac mitochondrial morphology and function |
| Q36752391 | Hypoxia signaling during acute lung injury |
| Q37373524 | Hypoxia signaling during intestinal ischemia and inflammation |
| Q33713383 | Hypoxia-induced deoxycytidine kinase expression contributes to apoptosis in chronic lung disease. |
| Q35998064 | Hypoxia-inducible factor 1 protects hypoxic astrocytes against glutamate toxicity |
| Q37448566 | Hypoxia-inducible factor-1α-dependent protection from intestinal ischemia/reperfusion injury involves ecto-5'-nucleotidase (CD73) and the A2B adenosine receptor |
| Q46175545 | Hypoxia-inducible factor-dependent induction of netrin-1 dampens inflammation caused by hypoxia. |
| Q26752304 | Hypoxia-inducible factors as molecular targets for liver diseases |
| Q38109802 | Hypoxia: a master regulator of microRNA biogenesis and activity |
| Q33569829 | Hypoxic repression of endothelial nitric-oxide synthase transcription is coupled with eviction of promoter histones |
| Q37625454 | Identification of hypoxia-inducible factor HIF-1A as transcriptional regulator of the A2B adenosine receptor during acute lung injury. |
| Q33725755 | Identification of vasodilator-stimulated phosphoprotein (VASP) as an HIF-regulated tissue permeability factor during hypoxia |
| Q90639932 | Inhibition of CXCR4 and CXCR7 Is Protective in Acute Peritoneal Inflammation |
| Q43111428 | Inhibition of neutrophil apoptosis by ATP is mediated by the P2Y11 receptor. |
| Q64108225 | Intestinal Epithelial Cells-Derived Hypoxia-Inducible Factor-1α Is Essential for the Homeostasis of Intestinal Intraepithelial Lymphocytes |
| Q46260887 | Intestinal hypoxia and hypoxia-induced signalling as therapeutic targets for IBD. |
| Q63977060 | Invited Lectures : Overviews Purinergic signalling: past, present and future |
| Q50849347 | Involvement of CD73, equilibrative nucleoside transporters and inosine in rhythm and conduction disturbances mediated by adenosine A1 and A2A receptors in the developing heart. |
| Q36430733 | Loss of CD73-mediated actin polymerization promotes endometrial tumor progression |
| Q39361006 | Mechanisms of attenuation of abdominal sepsis induced acute lung injury by ascorbic acid |
| Q91779682 | Metabolic Regulation of Macrophage Polarization in Cancer |
| Q90073357 | Metabolic adaptation of cancer and immune cells mediated by hypoxia-inducible factors |
| Q39923834 | Microarray analyses of hypoxia-regulated genes in an aryl hydrocarbon receptor nuclear translocator (Arnt)-dependent manner |
| Q28080772 | Molecular mechanisms of ischemic preconditioning in the kidney |
| Q39250668 | Molecular predictors of gemcitabine response in pancreatic cancer |
| Q64103114 | NR3C1 gene polymorphisms are associated with high-altitude pulmonary edema in Han Chinese |
| Q34011327 | Neutrophils as sources of extracellular nucleotides: functional consequences at the vascular interface |
| Q39523639 | New role of the human equilibrative nucleoside transporter 1 (hENT1) in epithelial-to-mesenchymal transition in renal tubular cells. |
| Q36127152 | Nickel-induced epithelial-mesenchymal transition by reactive oxygen species generation and E-cadherin promoter hypermethylation |
| Q38031634 | Nucleoside transporters: biological insights and therapeutic applications |
| Q37855808 | Nucleoside/nucleobase transporters: drug targets of the future? |
| Q33374284 | Oxygen-independent stabilization of hypoxia inducible factor (HIF)-1 during RSV infection |
| Q89839805 | P2X4 receptor exacerbates ischemic AKI and induces renal proximal tubular NLRP3 inflammasome signaling |
| Q91940114 | PAK inhibition by PF-3758309 enhanced the sensitivity of multiple chemotherapeutic reagents in patient-derived pancreatic cancer cell lines |
| Q33916670 | Partial netrin-1 deficiency aggravates acute kidney injury |
| Q37593569 | Perioperative organ injury |
| Q37082372 | Physiology of nucleoside transporters: back to the future. . . . |
| Q33890909 | Protection against acute kidney injury via A(1) adenosine receptor-mediated Akt activation reduces liver injury after liver ischemia and reperfusion in mice |
| Q41112476 | Protocol for a prospective, controlled, observational study to evaluate the influence of hypoxia on healthy volunteers and patients with inflammatory bowel disease: the Altitude IBD Study |
| Q92404916 | Purinergic Signaling in Pulmonary Inflammation |
| Q37139591 | Purinergic dysregulation in pulmonary hypertension |
| Q38034108 | Quintessential risk factors: their role in promoting cognitive dysfunction and Alzheimer's disease |
| Q39621896 | Regulation of ENT1 expression and ENT1-dependent nucleoside transport by c-Jun N-terminal kinase |
| Q24620317 | Regulation of neutrophil function by adenosine |
| Q39165553 | Repression of the equilibrative nucleoside transporters dampens inflammatory lung injury |
| Q37227567 | Retracted: Equilibrative nucleoside transporter (ENT)-1-dependent elevation of extracellular adenosine protects the liver during ischemia and reperfusion |
| Q37108355 | Role of adenosine A(2B) receptors in inflammation |
| Q36804999 | Role of extracellular nucleotide phosphohydrolysis in intestinal ischemia-reperfusion injury |
| Q33496725 | Selective deletion of the A1 adenosine receptor abolishes heart-rate slowing effects of intravascular adenosine in vivo |
| Q34707637 | Selective induction of endothelial P2Y6 nucleotide receptor promotes vascular inflammation |
| Q55263042 | Sequencing the exons of human glucocorticoid receptor (NR3C1) gene in Han Chinese with high-altitude pulmonary edema. |
| Q42003221 | Severe hypoxia induces complete antifolate resistance in carcinoma cells due to cell cycle arrest. |
| Q64900575 | Short-Term Hypoxia Dampens Inflammation in vivo via Enhanced Adenosine Release and Adenosine 2B Receptor Stimulation. |
| Q33807056 | Signaling through the A2B adenosine receptor dampens endotoxin-induced acute lung injury |
| Q33844658 | Signalling pathways involved in hypoxia-induced renal fibrosis |
| Q36539636 | Sustained adenosine exposure causes lung endothelial barrier dysfunction via nucleoside transporter-mediated signaling |
| Q55259961 | Switching-Off Adora2b in Vascular Smooth Muscle Cells Halts the Development of Pulmonary Hypertension. |
| Q33297014 | Targeted deletion of HIF-1alpha gene in T cells prevents their inhibition in hypoxic inflamed tissues and improves septic mice survival |
| Q93062525 | Targeting Adenosine in Cancer Immunotherapy to Enhance T-Cell Function |
| Q38209586 | Targeting CD73 and downstream adenosine receptor signaling in triple-negative breast cancer |
| Q34657382 | Targeting hypoxia signalling for the treatment of ischaemic and inflammatory diseases |
| Q33830064 | Targeting the A2B adenosine receptor during gastrointestinal ischemia and inflammation |
| Q35601599 | The 2',3'-cAMP-adenosine pathway |
| Q38686607 | The Adenosinergic System as a Therapeutic Target in the Vasculature: New Ligands and Challenges. |
| Q99565422 | The Association of FLT3-ITD Gene Mutation with Bone Marrow Blast Cell Count, CD34, Cyclin D1, Bcl-xL and hENT1 Expression in Acute Myeloid Leukemia Patients |
| Q38063159 | The CD39-adenosinergic axis in the pathogenesis of renal ischemia-reperfusion injury |
| Q38644137 | The Hypoxia-Adenosine Link during Inflammation. |
| Q48191363 | The Hypoxia-Adenosine Link during Intestinal Inflammation. |
| Q37440360 | The Janus-faced effects of hypoxia on astrocyte function |
| Q96230894 | The adenosine pathway in immuno-oncology |
| Q33692620 | The adenosine transporter, ENT1, in cardiomyocytes is sensitive to inhibition by ethanol in a kinase-dependent manner: implications for ethanol-dependent cardioprotection and nucleoside analog drug cytotoxicity |
| Q27014790 | The clinically relevant pharmacogenomic changes in acute myelogenous leukemia |
| Q90608608 | The failure of DAC to induce OCT2 expression and its remission by hemoglobin-based nanocarriers under hypoxia in renal cell carcinoma |
| Q35676172 | The hypoxia-inflammation link and potential drug targets |
| Q41678839 | The impact of hypoxia on tumor-associated macrophages |
| Q28473410 | The reno-vascular A2B adenosine receptor protects the kidney from ischemia |
| Q34307284 | The resurgence of A2B adenosine receptor signaling |
| Q36575943 | Transcriptional control of adenosine signaling by hypoxia-inducible transcription factors during ischemic or inflammatory disease |
| Q41871477 | Transgenic overexpression of CD39 protects against renal ischemia-reperfusion and transplant vascular injury |
| Q36593052 | Tubuloglomerular feedback and renal function in mice with targeted deletion of the type 1 equilibrative nucleoside transporter |
| Q48284423 | Unfolding Role of a Danger Molecule Adenosine Signaling in Modulation of Microbial Infection and Host Cell Response. |
| Q104491993 | Upregulated Hif-1α signaling pathway in high risk myelodysplastic syndrome and acute myeloid leukemia patients is associated with better response to 5-azacytidine - Data from the Hellenic MDS study group |
| Q35203103 | Use of a hanging weight system for coronary artery occlusion in mice |
| Q46626898 | Use of a hanging-weight system for liver ischemic preconditioning in mice |
| Q35859147 | Vasodilator phosphostimulated protein (VASP) protects endothelial barrier function during hypoxia |
| Q37593531 | miR-205 hinders the malignant interplay between prostate cancer cells and associated fibroblasts |
| Q58760423 | p21-activated kinase signalling in pancreatic cancer: New insights into tumour biology and immune modulation |
Search more.